Article
Stroma-specific gene expression signature identifies prostate cancer subtype with high recurrence risk
23 Feb 2024
Abstract excerpt
Current prognostic tools cannot clearly distinguish indolent and aggressive prostate cancer (PC). We hypothesized that analyzing individual contributions of epithelial and stromal components in localized PC (LPC) could improve risk stratification, as stromal subtypes may have been overlooked due to the emphasis on malignant epithelial cells. Hence, we derived molecular subtypes of PC using gene expression...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
